CYTOGENETIC ANALYSIS OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTRE REPORT

EHA Library, Ana Franjević, 421139

SHENGMA BIEJIA DECOCTION PROMOTES APOPTOSIS OF LEUKEMIA CELLS BY DOWN-REGULATING MITOCHONDRIAL FUSION

EHA Library, Wenjian Wei, 421140

STUDY OF THE MOLECULAR GENETIC PROFILE OF HIGH-RISK AML PATIENTS USING NEXT GENERATION SEQUENCING

EHA Library, Ekaterina Motyko, 421141

ACTIVATION OF C-MYC CONTRIBUTES TO VENETOCLAX-RESISTANCE IN ACUTE MYELOID LEUKEMIA VIA INHIBITION OF THE TRANSCRIPTION OF BIM

EHA Library, Guopan YU, 421142

THE PATHOGENESIS ROLE OF TRANSFORMING GROWTH FACTOR Β1 IN ACUTE MYELOBLASTIC LEUKEMIA WITH MATURATION RELATED THROMBOCYTOPENIA

EHA Library, Vira Barilka, 421143

ACUTE MYELOID LEUKEMIA AND ACQUIRED FACTOR VII DEFICIENCY - A NOT-SO-RARE ALLIANCE IN CLINICAL REALITIES

EHA Library, Ahlem Slama, 421144

FLOW-CYTOMETRY CHARACTERIZATION OF LEUKEMIC STEM CELLS AS AN INNOVATIVE AND PERSONALIZED BIOMARKER OF PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: AN EXPLORATIVE STUDY

EHA Library, Paola Pacelli, 421145

PROSPECTIVE EVALUATION OF THROMBO-HEMORRHAGIC EVENTS AND TISSUE FACTOR EXPRESSION IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA RECEIVING ATRA-BASED INDUCTION THERAPY

EHA Library, Francesca Schieppati, 421146

MOLECULAR MEASURABLE RESIDUAL DISEASE DETECTION IN AML WITH MUTATED CEBPA

EHA Library, Emma Boertjes, 421148

DUAL TARGETING OF MCL-1 AND SPHINGOLIPID METABOLISM: CAN IT BE A NOVEL APPROACH FOR AN EFFECTIVE TREATMENT OF ACUTE MYELOID LEUKEMIA?

EHA Library, Melis Kartal Yandim, 421149

TUMOR MICROENVIRONMENT IN NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE ROLE OF MESENCHYMAL STEM CELLS

EHA Library, Ludovica Calabretta, 421150

INFLAMMATION AND COAGULATION PARAMETERS AS RISK FACTORS FOR DEVELOPMENT OF THROMBOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Emilija Zivkovic, 421151

PROGNOSTIC RELEVANCE OF VARIANT ALLELIC FREQUENCY FOR TREATMENT OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Rafael Colmenares, 421152

CD9 AS A PROGNOSTIC MARKER IN ACUTE MYELOID LEUKEMIA

EHA Library, sabrine khirallah, 421154

PROGNOSTIC ROLE OF CD81 IN ACUTE MYELOID LEUKEMIA

EHA Library, sabrine khirallah, 421155

NETWORK BASED STRATIFICATION HELPS REFINE STRATIFICATION OF INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA SAMPLES

EHA Library, Ankita Srivastava, 421156

DIFFERENCES IN IMMUNE TRANSCRIPTOMIC PROFILE ARE ASSOCIATED WITH RESPONSE TO AZACITIDINE AND VENETOCLAX IN NEWLY DIAGNOSED UNFIT-FOR-CHEMOTHERAPY ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Letizia Zannoni, 421157

A HIGH-THROUGHPUT DRUG SCREENING METHOD IDENTIFIES NOVEL, SYNERGISTIC DRUG COMBINATIONS WITH STATINS IN PAEDIATRIC AML

EHA Library, Evangeline Johnston, 421158

FREQUENT TRUNCATING MUTATIONS IN TET2 GENE AND GLOBAL DNA HYPERMETHYLATION CHARACTERIZES ACUTE MYELOID LEUKEMIA WITH ISOLATED TRISOMY 4

EHA Library, sayantanee Dutta, 421159

BCL11B REARRANGEMENT DEFINES A NEW PEDIATRIC ACUTE LEUKEMIA ENTITY

EHA Library, Valeria Ceolin, 421160

CYTOKINE AND CHEMOKINE PROFILING REVEALS DISTINCT SIGNATURES IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Stephanie Sendker, 421161

CO-MUTATION LANDSCAPE AND ITS PROGNOSTIC IMPACT ON NEWLY DIAGNOSED ADULT PATIENTS WITH NPM1 MUTATED DE NOVO ACUTE MYELOID LEUKEMIA

EHA Library, Yiyi Yao, 421162

GILTERITINIB CAUSES CELLULAR CHANGES INDEPENDENT OF FLT3 AND LEADING TO DRUG RESISTANCE IN AML

EHA Library, Martina Ceckova, 421163

CORE TARGETS INTERACTOMICS UNVEILED THE MECHANISM OF ACTION IN NOVEL DRUG COMBINATORIAL THERAPY OF AML

EHA Library, Ehsan Zangene, 421164

BCL2-TCL1 AS A PROPOSED NEW COMBINATION FOR THE DETERMINATION OF MEASURABLE RESIDUAL DISEASE BY FLOW CYTOMETRY IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

EHA Library, Angeliki Kotsiafti, 421165

EVALUATION OF NOVEL FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA

EHA Library, Jan Rataj, 421166

GP6: A NOVEL HEMATOLOGIC MALIGNANCY PREDISPOSING GENE?

EHA Library, Cristina Natalucci, 421168

AML WITH PLASMACYTOID DENDRITIC CELL EXPANSION IN TWO CHILDREN WITH UNDERLYING CONGENITAL BONE MARROW FAILURE SYNDROME

EHA Library, Nina Friesgaard Øbro, 421169

THE RISK OF SECOND PRIMARY MALIGNANCY IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS TREATED WITH ARSENIC TRIOXIDE

EHA Library, Ming-Hsien Lin, 421170

CLINICAL CHARACTERISTICS AND OUTCOMES OF NUP98 REARRANGEMENT IN ADULTS WITH ACUTE LEUKEMIA

EHA Library, Katherine Klein, 421171

CLINICAL CHARACTERISTICS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA PATIENTS WITH RUNT-RELATED TRANSCRIPTION FACTOR 1 MUTATION: A SINGLE-CENTER RETROSPECTIVE ANALYSIS

EHA Library, Linya Wang, 421173

LEUKOCYTOSIS IN LOW-INTERMEDIATE RISK ACUTE PROMYELOCYTIC LEUKEMIA DURING ATRA-ATO INDUCTION THERAPY: A REAL-LIFE STUDY

EHA Library, Laura Cicconi, 421174

RELEVANCE OF DISCRIMINATION OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) FROM RELATED HEMATOLOGIC MALIGNANCIES

EHA Library, Paolo Mazzeo, 421175

DOES MRD ASSESSMENT ALLOW FOR EARLY PREDICTION OF EXTRAMEDULLARY RELAPSE IN PATIENTS WITH MYELOID NEOPLASM AFTER ALLOGENEIC STEM CELL TRANSPLANTATION?

EHA Library, Jule Ussmann, 421176

PATIENT INVOLVEMENT IN THE TRIAL DESIGN OF ALIDHE: A PHASE 3B STUDY OF IVOSIDENIB + AZACITIDINE IN PATIENTS WITH NEWLY DIAGNOSED IDH1 MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Samantha Nier, 421177

PROGNOSTIC SIGNIFICANCE OF THE LEVEL OF C-REACTIVE PROTEIN AND IMMUNOPHENOTYPE IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY

EHA Library, Inga MANDAC ROGULJ, 421179

VENETOCLAX IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AGED ≥60 YEARS: RESULTS FROM THE AML REAL WORLD EVIDENCE (ARC) INITIATIVE IN CHINA

EHA Library, Jianxiang Wang, 421180

REAL-WORLD ANTIEMETIC USE AND ITS ASSOCIATION WITH DURATION OF ORAL AZACITIDINE MAINTENANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN THE UNITED STATES

EHA Library, Thomas Leblanc, 421181

FEASIBILITY OF CONSECUTIVE DAY DOSING OF HIGH DOSE CYTARABINE VIA CONTINUOUS AMBULATORY DELIVERY DEVICE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, KYE LING WONG, 421182

LEVOFLOXACIN PREVENTS FEBRILE NEUTROPENIA DURING CYTARABINE CONSOLIDATION (IDAC/HIDAC) IN ACUTE MYELOID LEUKEMIA

EHA Library, Warangkana Assawawongsawat, 421183

THE IMPACT OF DELAYED HEMATOLOGICAL RECOVERY ON THE OUTCOME IN ACUTE MYELOID LEUKEMIA WITH NEGATIVE MINIMAL RESIDUAL DISEASE POST INDUCTION I IN CHILDREN

EHA Library, nissma shhain, 421184

CHARACTERIZATION OF ACUTE MYELOID LEUKAEMIA PATIENTS WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS, WITHIN A PORTUGUESE TERTIARY CARE HOSPITAL

EHA Library, Andre Pardal, 421186

FEASIBILITY OF POST-REMISSION ARA-C CONSOLIDATION IN PATIENTS WITH AML AFTER CPX-351 INDUCTION.

EHA Library, Salvatore Perrone, 421187

GENETIC, EPIGENETIC, AND CLINICAL SIGNIFICANCE OF WILMS’ TUMOR 1 (WT1) GENE IN ACUTE MYELOID LEUKEMIA

EHA Library, HARSH GOEL, 421188

PREVALENCE OF CT-DEFINED LOW MUSCLE QUANTITY AND QUALITY IN OLDER AML PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY: RESULTS FROM A MULTICENTER BRAZILIAN COHORT

EHA Library, Frederico Lisboa Nogueira, 421189

EFFICACY AND TOLERABILITY OF TREATMENT WITH VENETOCLAX AND AZACITIDINE FOR 5 DAYS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE.

EHA Library, Oriana Francesca Bianco, 421190

SAFETY OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING GEMTUZUMAB OZOGAMICIN AND PROCEEDING TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Partow Kebriaei, 421191

RISK-STRATIFIED TREATMENT OF SONROTOCLAX COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A MULTICENTER, PHASE II STUDY

EHA Library, Min Wu, 421192

REAL-WORLD TREATMENT OUTCOMES AND SAFETY OF REDUCED DOSE VENETOCLAX PLUS ANTIFUNGAL AGENTS FOR ACUTE MYELOID LEUKEMIA, A SINGLE HOSPITAL EXPERIENCE IN TAIWAN

EHA Library, Sheng-Yen Hsiao, 421193

THE CHARACTERS AND PROGNOSTIC ANALYSIS OF THERAPY-RELATED ACUTE MYELOID LEUKEMIA PATIENTS IN CHINA: A MULTICENTER STUDY

EHA Library, Feifei Tang, 421194

IMPROVING BONE MARROW MICROENVIRONMENT IN ACUTE MYELOGENOUS LEUKEMIA ELDERLY PATIENTS (AML) THROUGH 2 MONTHS OF PRE-INDUCTION WITH AZACITIDINE AND VENETOCLAX

EHA Library, Maher Salamoon, 421195

PRE-INDUCTION WITH FOUR WEEKLY HIGH-DOSE CYTARABINE, REDUCES MORTALITY RATE AND PROLONGS PROGRESSION FREE SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA (AML), A COMPARATIVE STUDY

EHA Library, Maher Salamoon, 421196

RELAPSE-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING POST-HEMATOPOIETIC STEM CELL TRANSPLANT MAINTENANCE THERAPY

EHA Library, Melinda Hamilton, 421197

CLINICAL FEATURES AND LONG-TERM OUTCOMES OF PEDIATRIC DE NOVO ACUTE MYELOID LEUKEMIA IN CHINA WITH OR WITHOUT SPECIFIC GENE ABNORMALITIES: A RETROSPECTIVE STUDY OF PATIENTS TREATED ON BCH-AML 2005

EHA Library, Hongbo He, 421198

REVISITING THE REAL-WORLD PROGNOSIS OF INTENSIVE CHEMOTHERAPY IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS IN THE VENETOCLAX ERA.

EHA Library, Takeshi Hagino, 421199

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM PROGNOSTIC SCORE

EHA Library, Philip Haddad, 421200

VICEROY: A PHASE I/II STUDY OF GILTERITINIB, VENETOCLAX AND AZACITIDINE COMBINATION IN PATIENTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE INDUCTION CHEMOTHERAPY

EHA Library, Naval Daver, 421201

REAL WORLD DATA OF FLT3-MUTATED AML IN URUGUAY

EHA Library, Matilde Boada, 421202

GENOMIC CHARACTERIZATION ANALYSIS OF ACUTE MYELOID LEUKEMIA PATIENTS WITH T(8;21) VARIANT TRANSLOCATION

EHA Library, Bingbing Han, 421203

GENETIC ABNORMALITIES ASSOCIATED WITH OUTCOMES IN PATIENTS WITH NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Shunjie Yu, 421204

CLINICAL IMPLICATION OF RAS MUTATION IN LOW RISK PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Nadine Gebril, 421205

GERIATRIC FUNCTIONAL ASSESSMENT AS AN EARLY PROGNOSTIC TOOL FOR ELDERLY PATIENTS WITH MYELOID DISEASE: A PROSPECTIVE STUDY

EHA Library, Hyeoung-Joon Kim, 421206

EFFICACY AND TOLERABILITY OF COMBINED REGIMENS WITH MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR REFRACTORY AND RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Li Liu, 421207

VENETOCLAX PLUS CACAG FOR REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA：A SINGLE-ARM，PHASE Ⅱ TRIAL

EHA Library, Yanan Wen, 421208

A FIRST-IN-HUMAN, PHASE 1, DOSE ESCALATION STUDY OF SGR-2921 AS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME

EHA Library, Pau Montesinos, 421209

VENETOCLAX ADDED TO CLAG REGIMEN IMPROVES THE OUTCOME OF PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Guopan YU, 421210

IN ACUTE MYELOID LEUKEMIA, RESPONSE TO VENETOCLAX COMBINATIONS PREDICTS COMPARABLE SURVIVAL IRRESPECTIVE OF THERAPEUTIC LINE

EHA Library, Alessandro Bosi, 421211

THE EFFICACY AND SAFETY OF SELINEXOR COMBINED WITH VENETOCLAX FOR UNTREATED ELDERLY UNFIT ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Fei Li, 421212

REAL WORD EXPERIENCE WITH VENETOCLAX-BASED THERAPY IN ACUTE MYELOID LEUKEMIA IN CZECH REPUBLIC

EHA Library, Barbora Dluhosova, 421213

EXPLORATION OF PROGNOSTIC FACTORS IN CHILDREN ACUTE MYELOID LEUKEMIA WITH T(8;21)(Q22;Q22.1) MOLECULAR CHARACTERISTICS AND TREATMENT OPTIONS

EHA Library, Xin Su, 421214

TRIPLET THERAPY WITH GILTERITINIB, VENETOCLAX, AND AZACITIDINE FOR RELAPSED/REFRACTORY FLT3MUT ACUTE MYELOID LEUKEMIA

EHA Library, Qiang Fu, 421215

EFFICACY AND SAFETY ANALYSIS OF AZACITIDINE THERAPY AFTER HAPLOIDENTICAL TRANSPLANTATION FOR PEDIATRIC ACUTE MYELOID LEUKEMIA PATIENTS WHO WERE MINIMAL RESIDUAL DISEASE-POSITIVE BEFORE TRANSPLANT

EHA Library, Huili Zhu, 421216

FEATURES AND PROGNOSTIC SIGNIFICANCE OF SOLUBLE TIM-3 AND ITS LIGANDS GAL-9 AND CEACAM1 LEVELS IN THE DIAGNOSTIC BONE MARROWS OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Ya-Zhen Qin, 421217

A COMPOSITION OF MULTI-MARKERS CAN HIGH EFFICIENTLY   SCREEN  ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Hui Wang, 421218

QUANTUM-FIRST: SAFETY BY TREATMENT (TX) PHASE AND BY AGE IN NEWLY DIAGNOSED (ND) PATIENTS WITH FMS-LIKE TYROSINE KINASE 3–INTERNAL TANDEM DUPLICATION (FLT3-ITD) POSITIVE ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Harry Erba, 421219

CONSTRUCTION AND VALIDATION OF AN ASSISTANT DECISION-MAKING MODEL FOR PLATELET TRANSFUSION REFRACTORINESS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Xiaowen Tang, 421220

VENETOCLAX PLUS HOMOHARRINGTONINE WITH CYTARABINE AND ACLARUBICIN AS INDUCTION THERAPY FOR YOUNG ADULTS WITH DE NOVO ACUTE MYELOID LEUKEMIA: A PROSPECTIVE, SINGLE-ARM, MULTICENTER, PHASE 2 STUDY

EHA Library, Huafeng Wang, 421221

A REAL-WORLD STUDY OF THE EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN TREATING PATIENTS WITH FAVORABLE-RISK ACUTE MYELOID LEUKEMIA

EHA Library, Qi Chen, 421222

PROPHYLACTIC THERAPY OF EPIGENETIC AGENTS IN HIGH-RISK AML WITH RUNX1-RUNXT1 AFTER ALLO-HSCT

EHA Library, Erlie Jiang, 421223

CHARACTERIZATION OF ADULT PATIENTS WITH CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA IN CHILE. RESULTS OF THE GRELAM-CHILE ON BEHALF OF THE AML EPIDEMIOLOGICAL REGISTRY FROM PETHEMA STUDY GROUP.

EHA Library, Monica Alejandra Romero Riquelme, 421224

THE CLINICAL EFFICACY OF DARATUMUMAB-BASED REGIMEN IN RELAPSED/REFRACTORY ACUTE LEUKEMIA A SINGLE CENTER RETROSPECTIVE STUDY

EHA Library, Jing Li, 421225

REAL-LIFE MOROCCAN EXPERIENCE OF VENETOCLAX, AZACITIDINE AND ANTIFUNGAL PROPHYLAXIS (VORICONAZOLE) IN AML AND HIGH-RISK MDS.

EHA Library, Amal Terfaï, 421226

EFFECTIVE PROGNOSTIC MODEL FOR THERAPY RESPONSE PREDICTION IN ACUTE MYELOID LEUKEMIA PATIENTS RECEIVED INDUCTION THERAPY WITH ANTHRACYCLINES

EHA Library, Maria Kolesnikova, 421228

AZACITIDINE AND VENETOCLAX THERAPY AND TUMOUR LYSIS RATES IN OXFORD UNIVERSITY HOSPITALS

EHA Library, Ashlyn Chee, 421230

EFFICACY AND SAFETY OF NOVEL THERAPY APPROACHES FOR ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS: UKRAINIAN PROSPECTIVE STUDY

EHA Library, Zinaida Stupakova, 421231

ROLE AND IMPACT OF NEXT GENERATION SEQUENCING IN AML TREATMENT IN RESOURCE CONSTRAINT SETTING- A SINGLE CENTRE EXPERIENCE FROM INDIA

EHA Library, PRATIBHA DHIMAN, 421232

A PROSPECTIVE STUDY OF ALL-TRANS RETINOIC ACID PLUS VENETOCLAX AND AZACITIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Chengyuan Gu, 421233

PREDICTIVE ROLE OF PLATELETS RECOVERY IN THE SETTING OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH AZACITIDINE-VENETOCLAX

EHA Library, Natalia Cenfra, 421234

GENETIC ABNORMALITIES PREDICT OUTCOMES IN PATIENTS WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIAS

EHA Library, Shunjie Yu, 421235

DEVELOPMENT OF A PHASE-I-TRIAL EVALUATING A MULTI-PEPTIDE VACCINE DIRECTED AGAINST ACUTE MYELOID LEUKEMIA STEM AND PROGENITOR CELLS

EHA Library, Susanne Jung, 421236

EFFECT OF SORAFENIB ON PROGNOSIS IN PATIENTS WITH LOW ALLELIC RATIO FLT3-ITD ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, qiannan Yang, 421237

RISK FACTORS FOR DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA DURING NOCYTOSTATIC THERAPY

EHA Library, Arina Semenova, 421238

ABC-14 REGIMEN (AZACITIDINE, VENETOCLAX AND CHIDAMIDE) IS COMPARABLE TO “3+7” REGIMEN IN DE NOVO AML: A REAL-WORLD EXPERIENCE FROM ABC-14 COLLABORATION GROUP

EHA Library, Ping Wu, 421239

RESULTS OF ALLOGENIC STEM CELL TRANSPLANTATION IN ADULT CHILEAN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA. ANALYSIS OF THE GRELAM-CHILE ON BEHALF OF THE AML REGISTRY FROM THE PETHEMA STUDY GROUP

EHA Library, Monica Alejandra Romero Riquelme, 421240

MULTICENTER EVALUATION OF TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL): RESULTS OF THE EPIDEMIOLOGICAL REGISTRY OF THE PETHEMA GROUP IN CHILE.

EHA Library, Yaima Gutierrez, 421241

OUTCOMES OF RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN: A MONOCENTRIC EXPERIENCE

EHA Library, Hanen Charfi, 421242

MAST CELL LEUKEMIA: A SEER REGISTRY- BASED ANALYSIS OF SURVIVAL OUTCOMES FROM 2000-2020

EHA Library, Sruthi Vellanki, 421243

VENETOCLAX COMBINATION THERAPIES IN PEDIATRIC PATIENTS WITH MYELOID NEOPLASMS: A MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Alicia Pablos Lopez, 421244

INCIDENCE AND PREDISPOSING FACTORS OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE NON-PROMYELOCYTIC MYELOID LEUKEMIA: EXPERIENCE FROM TWO CENTERS

EHA Library, Vasiliki Gkalea, 421245

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN FLT3-TKD POSITIVE ACUTE MYELOID LEUKAEMIA IN THE MIDOSTAURIN-BASED THERAPY ERA: A STUDY OF THE POLISH ADULT LEUKAEMIA GROUP (PALG)

EHA Library, Elzbieta Patkowska, 421246